Rou Gui

Cinnamomum cassia Presl

Also known as: Cinnamon bark(English) 肉桂(Chinese)

Yukgye肉桂 육계 Quế nhục(source gives Cinnamomum spp.) Jou Kuei

Updated October 23, 2026 · Not yet clinically reviewed

Safety at a glance

High risk

Do not combine with Chi Shi Zhi (十九畏)

Note

5 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
warming interior
Temperature
Hot
Taste
Pungent,Sweet
Channels
Heart,Liver,Spleen,Kidney

Functions

Tonifies Kidney Yang; Guides Fire Back to Its Source; Dispels Cold and Alleviates Pain; Warms the Channels and Disperses Cold; Tonifies Qi and Generates Blood

Traditional uses

Rou Gui (cinnamon bark) is among the warmest and most potent herbs in Chinese medicine, used to restore and warm Kidney Yang, dispel cold from all channels, and invigorate Blood circulation. It is a primary herb for cold patterns involving the lower back and knees, frigid extremities, impotence, frequent urination, and abdominal pain from cold. Its capacity to return fire to its source — drawing floating Yang back to the Kidney — makes it essential in formulas for severe Yang deficiency with upward-floating heat signs.

Western herbalism

Properties: stimulant, carminative, antispasmodic, diaphoretic, antimicrobial

Pharmacological effects

  • Hypotensive: Mixture with Fu Zi lowered BP in rats with adrenocortical (adrenal-burn) hypertension but not renal hypertension, apparently by normalizing the depressed adrenal gland's activity.
  • Coronary/cerebral blood flow and myocardial ischemia: Decoction increased coronary flow in isolated guinea pig heart; oral 1.2 g/kg for 6 days improved pituitrin-induced ischemia in rabbits; i.v. 2 g/kg in dogs increased coronary sinus and cerebral flow; peripheral vasodilation suggested.
  • Antiulcerative: Aqueous extract 100 mg/kg i.p. prevented stress and serotonin-induced ulcers in rats, inhibiting gastric secretion and promoting mucosal blood flow; phenylpropanoid glycosides identified as active.
  • Leukogenic and radioprotective: Sodium cinnamate raised leukocytes 150–200% in dogs and improved survival of irradiated mice and dogs.
  • Farnesyl-protein transferase inhibition: 2'-Hydroxycinnamaldehyde inhibited FPTase, relevant to ras oncogene activation (in vitro).
  • Antimicrobial: Decoction antifungal in vitro; essential oil bactericidal, more potent against gram-positive bacteria.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 353.

Formulas using this herb

76 of 76 formulas

Botanical

Cinnamomum cassia (L.) J.Presl (Lauraceae) is an evergreen tree native to southern China and mainland Southeast Asia, reaching 10 to 20 meters in height with a straight trunk and a dense, dark green crown; in cultivation it is often coppiced as a tall shrub or small tree for repeated bark harvest. The bark of mature trees is thick, rough and grayish-brown externally, with an inner bark of warm reddish-brown that is strongly aromatic. The leaves are alternate to subopposite, oblong to elliptic-lanceolate, 8 to 20 cm long, leathery, dark green and glossy above, paler beneath, with three prominent longitudinal veins running from the base. Small, fragrant, yellowish-white flowers are borne in axillary and terminal panicles, each with six perianth segments. The fruit is a small ovoid drupe seated in an enlarged cupule. The peeled, dried, naturally rolled inner bark constitutes Rou Gui, harvested in autumn from trees at least five to ten years old.

Family
Lauraceae
Pharmaceutical name
Cortex Cinnamomi
Parts used
bark
Plant type
tree
Native region
Fujian, Guangdong, Guangxi, Yunnan

Constituents

(E)-Cinnamaldehyde

Phenylpropanoid (aromatic aldehyde) · Dominant component of the bark essential oil; the Chinese Pharmacopoeia requires not less than 85 percent (v/v) cinnamaldehyde in distilled cassia bark oil (Rou Gui You). Reported essential oil yield 0.41-2.61 percent w/w from stem bark and 2.70-3.11 percent w/w from branch bark.

The principal pungent and warming constituent of the bark and a TRPA1 agonist, responsible for the local vasodilator flush and much of the antimicrobial activity. It is also a moderate to strong skin sensitiser in the local lymph node assay, with EC3 values reported as low as 0.2 percent, which is a concern for topical cassia oil rather than for an oral decoction.

Coumarin

Benzopyranone (simple coumarin) · 2650-7017 mg/kg, mean 3856 mg/kg, across 60 retail ground cassia samples in one Czech market survey; approximately 12.07 mg per 4 g of cinnamon bark in Japanese Kampo decoction material. Cinnamomum verum bark is by comparison essentially coumarin-free (below the limit of detection in the same survey).

Cassia is the high-coumarin cinnamon, and coumarin is the reason Rou Gui carries a liver-safety caveat that Ceylon cinnamon does not. EFSA set a tolerable daily intake of 0.1 mg/kg body weight per day on the basis of hepatotoxicity in a two-year dog study; hepatotoxicity is thought to proceed through the minor CYP-mediated 3,4-epoxide pathway rather than the major 7-hydroxylation route. Coumarin is not itself an anticoagulant, a point routinely confused in consumer material: warfarin and dicoumarol are 4-hydroxycoumarins, a different chemistry.

Cinnamic acid

Phenylpropanoid (aromatic carboxylic acid) · Minor bark constituent, in part an oxidation product of cinnamaldehyde

A marker compound used alongside cinnamaldehyde in quality control of cassia bark. It is more water-soluble than cinnamaldehyde and so carries over into an aqueous decoction more reliably than the volatile fraction does.

Cinnamyl acetate

Phenylpropanoid ester · Secondary component of the bark volatile oil

Contributes to the aroma of the bark oil and is one of the volatiles whose proportion varies markedly with tree age and bark segment, which is part of why cassia bark quality is graded by thickness and oil content.

2-Methoxycinnamaldehyde

Phenylpropanoid (aromatic aldehyde) · Minor volatile constituent of the bark

A methoxylated analogue of cinnamaldehyde with reported anti-inflammatory and antiproliferative activity in cell models. The evidence is preclinical only and should not be presented as a clinical property of the decoction.

Procyanidin B2 and related proanthocyanidins

Condensed tannins (flavan-3-ol oligomers) · Non-volatile polyphenol fraction of the bark; (-)-epicatechin and procyanidins B2, B4 and C1 have been isolated

The water-soluble polyphenol fraction, and therefore the part of the bark most heavily represented in a decoction relative to the volatile oil. These oligomers carry most of the antioxidant activity and the in vitro insulin-signalling effects that motivated the cinnamon diabetes trials.

Drug interactions

Warfarin and other vitamin K antagonists

Moderate · Potentially significant if high-dose cassia extract is added to stable anticoagulation, but the mechanism is metabolic rather than pharmacodynamic · Evidence level: Possible

The common claim that cassia thins the blood because it contains coumarin is pharmacologically wrong: plain coumarin has no vitamin K epoxide reductase activity, and the anticoagulant coumarins are 4-hydroxy derivatives. The plausible route is metabolic. Coumarin is a CYP2A6 substrate and cinnamaldehyde inhibits CYP2A6, while coumarin has been reported to affect CYP2D6 and CYP3A4. Documented case reports of INR disturbance attributable to cinnamon are sparse and confounded, so this remains a mechanistic rather than a clinically demonstrated interaction.

Clinical note: Culinary and ordinary decoction amounts are unlikely to matter. If a concentrated cassia bark extract is started or stopped in an anticoagulated patient, check the INR within one to two weeks rather than assuming either direction of effect.

Paracetamol (acetaminophen), methotrexate and other hepatotoxic drugs

Moderate · Additive hepatic burden at sustained high cassia intake; not established at usual decoction doses · Evidence level: Possible

Coumarin hepatotoxicity in susceptible individuals is the basis of the EFSA tolerable daily intake of 0.1 mg/kg body weight per day. The best human data specific to cinnamon bark as a medicine is a retrospective analysis of 129 Japanese outpatients on cinnamon-containing Kampo formulae: median coumarin intake was 0.113 mg/kg/day and 76 percent of patients exceeded the tolerable daily intake, yet abnormal liver function was no more frequent in that group (17.3 percent) than below it (19.4 percent), and no case was attributed to cinnamon bark. The honest reading is that the regulatory limit is regularly exceeded by therapeutic Rou Gui doses without a demonstrated signal, but that the margin over the limit is real and additive burden should not be ignored.

Clinical note: Do not treat the tolerable daily intake as a hard ceiling for short courses, but avoid open-ended daily high-dose cassia in patients with existing liver disease or on other hepatotoxic drugs, and check liver function if a course runs for months.

Metformin, sulfonylureas and insulin

Minor · Theoretical additive glucose lowering; the effect size in trials is not established · Evidence level: Possible

Cassia proanthocyanidins improve insulin signalling in cell and animal models, and this drove a series of human trials. The Cochrane review of 10 randomised trials in 577 participants found insufficient evidence that cinnamon lowers HbA1c, fasting glucose or lipids, and the pooled trials mixed Cinnamomum cassia with other Cinnamomum species. An additive hypoglycaemic effect is therefore plausible but unproven.

Clinical note: No routine dose change is warranted. If a diabetic patient starts a high-dose cassia extract, ask them to monitor capillary glucose for the first fortnight rather than adjusting therapy pre-emptively.

Cinnamomum burmannii or Cinnamomum loureiroi supplied as Rou Gui

Moderate · Substitution changes coumarin exposure without changing the label · Evidence level: Established

The commercial cinnamon trade does not respect binomials. Bark from Cinnamomum burmannii (Indonesian or Padang cassia) and Cinnamomum loureiroi (Saigon cassia) is sold interchangeably as cassia, and Cinnamomum burmannii in particular carries coumarin at the high end of the cassia range. Conversely, Cinnamomum verum sold as cinnamon is essentially coumarin-free but is not the drug Rou Gui names. Species identity therefore determines the single safety-relevant variable in this herb.

Clinical note: Source Rou Gui from a supplier that identifies the species and, for long courses, can supply a coumarin figure. A generic cinnamon certificate of analysis is not adequate for a drug whose only material hazard is species-dependent.

Gui Zhi (Ramulus Cinnamomi, cinnamon twig from the same plant)

Minor · Part substitution, not a toxicological hazard, but a therapeutic identity error · Evidence level: Established

Rou Gui is the thick trunk or branch bark and Gui Zhi is the young twig of the same species. They are separate Chinese Pharmacopoeia entries with different essential oil content and different classical indications, Rou Gui warming the interior and guiding fire back to its source, Gui Zhi releasing the exterior. Twig material has substantially lower volatile oil than trunk bark, so substitution under-doses the pungent fraction while leaving the label intact.

Clinical note: Confirm on receipt that the material is bark, not twig, and do not import Gui Zhi trial evidence into a Rou Gui monograph.

Dosage

FormAmountFrequencyNotes
decoction1–5 gDaily
中国药典 2020 【用法与用量】1~5g。 【注意】有出血倾向者及孕妇慎用;不宜与赤石脂同用。 【性味与归经】辛、甘,大热。归肾、脾、心、肝经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Rou Gui + Huang Lian黄连

Together they clear Heart fire and warm the Kidney, restoring communication between Heart and Kidney to calm the spirit.

Classic indication: insomnia and palpitations from Heart and Kidney failing to communicate.

Core pair of a classical formula — Jiao Tai Wan, Han Shi Yi Tong (Han Mao, 1522)

Rou Gui + Zhi Fu Zi制附子

Two hot herbs that together warm and tonify Kidney yang and guide fire back to its source, more strongly warming the life-gate fire than either alone.

Kidney yang deficiency with cold limbs, sore lower back and impotence. Both are contraindicated in pregnancy and yin deficiency with heat.

Core pair of a classical formula — You Gui Wan, Jing Yue Quan Shu (Zhang Jingyue)

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
2
Observational / case report
1

Cinnamon for diabetes mellitus

Leach MJ, Kumar S · Cochrane Database of Systematic Reviews · 2012 · systematic review

Systematic review / meta-analysis · Not yet verified

Ten randomised controlled trials in 577 participants with type 1 or type 2 diabetes. The review found insufficient evidence to support the use of cinnamon for diabetes, with no significant difference from placebo, active medication or no treatment in HbA1c and inconsistent effects on fasting plasma glucose and lipids. Trial quality was poor and the pooled studies used more than one Cinnamomum species, so the result cannot be read as specific to Cinnamomum cassia.

doi:10.1002/14651858.CD007170.pub2

Efficacy of herbal medicine (cinnamon/fennel/ginger) for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials

Xu Y, Yang Q, Wang X · Journal of International Medical Research · 2020 · systematic review

Systematic review / meta-analysis · Verified

Pooled randomised trials of cinnamon, fennel and ginger against placebo and against conventional analgesia in primary dysmenorrhoea. The herbs reduced pain intensity relative to placebo; the trials were small, heterogeneous and largely from a single region, and the cinnamon arms did not consistently specify the Cinnamomum species used, which limits how far the result can be attributed to Cinnamomum cassia bark specifically.

doi:10.1177/0300060520936179

The Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark

Iwata N, Kainuma M, Kobayashi D, Kubota T, Sugawara N, Uchida A, et al. · Frontiers in Pharmacology · 2016 · cohort

Observational / case report · Not yet verified

Retrospective analysis of 129 Japanese outpatients prescribed a cinnamon-containing Kampo formula, with liver function measured before and after treatment. Coumarin content varied from 0.05 to 1.65 mg per gram of cinnamon bark and daily coumarin intake from 0.15 to 5.63 mg. Median intake was 0.113 mg/kg/day and 76 percent of patients exceeded the European tolerable daily intake of 0.1 mg/kg/day, yet the incidence of abnormal liver function was similar above and below that threshold (17.3 versus 19.4 percent) and no case of liver injury was attributed to cinnamon bark. This is the most directly relevant human safety dataset for medicinal cassia bark.

doi:10.3389/fphar.2016.00174

Safety

Contraindications

Its use is cautious in patients with hemorrhagic tendency and pregnant women. It is not suited to use together with Halloysitum Rubrum ( chi shi zhi ).

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 161–167.

Side effects

  • Dizziness, blurred vision, raised intraocular pressure, cough, oliguria, thirst and rapid pulse in patients taking 36 g of powdered herb at once.
  • Cinnamic aldehyde: low doses reduce animal activity; high doses cause strong spasm, motor disturbance, shortness of breath and death from respiratory paralysis.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 353.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Incompatibilities (十八反 / 十九畏)

  • 十九畏: Rou Gui × Chi Shi Zhi — avoid combining with Chi Shi Zhi / Halloysite

Cultural and historical

Shen Nong Ben Cao Jing (Divine Husbandman's Classic of Materia Medica) · Eastern Han dynasty, compiled c. 200 CE

Cinnamon enters the Chinese materia medica here as two separate upper-class entries, Mu Gui and Jun Gui, both cited for warming and for dispersing cold. The later division of the drug into Rou Gui (thick trunk and branch bark) and Gui Zhi (young twig) postdates this text, so classical passages under the general name Gui cannot be assumed to describe the bark drug now dispensed as Rou Gui.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Sorts the cinnamon drugs by part and by bark thickness, treating the thick, heavily oiled trunk bark as the strongest interior-warming grade and separating it from the twig. This is the source that fixes the modern grading of Rou Gui by bark thickness and volatile oil content, a criterion still used commercially.

Yin Shan Zheng Yao (Principles of Correct Diet), Hu Sihui · Yuan dynasty, 1330

Listed among the seasonings as pungent, very hot and toxic, used for cold phlegm and to benefit the liver and lung.

References

  1. Blahová J, Svobodová Z. Assessment of Coumarin Levels in Ground Cinnamon Available in the Czech Retail Market. The Scientific World Journal. 2012 doi:10.1100/2012/263851
  2. EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). Coumarin in flavourings and other food ingredients with flavouring properties - Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). EFSA Journal. 2008 doi:10.2903/j.efsa.2008.793
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice